Cardiff Oncology's Shares Plummet After Leadership Departures

martes, 27 de enero de 2026, 10:35 am ET1 min de lectura
CRDF--

Cardiff Oncology shares plunged 35% to a 52-week low after the cancer drug developer announced the resignation of its CEO and CFO. The company's stock price dropped following the leadership shakeup, with no immediate replacement for the outgoing executives announced.

Cardiff Oncology's Shares Plummet After Leadership Departures

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios